https://www.thebodypro.com/category/efavirenz-sustiva-stocrin

Efavirenz (Sustiva, Stocrin)

The Latest

hole in a fence
News

This Week in HIV Research: Removing Barriers to Better Care

Oct. 31, 2019: HCV treatment efficacy regardless of injection drug use; chronic pain, marijuana, and prescription opoids; the most urgent HIV training priorities; neuro effects of switching from Atripla to Complera.

Promo Image
News

This Week in HIV Research: HIV Is Not an Obstacle

April 11, 2019: acute syphilis and virologic control; neuropsychological performance after switching off efavirenz; structural LGBTQ stigma and HIV criminalization in U.S. states; lung cancer resection surgery in people with HIV.

Dolutegravir More Effective Than Efavirenz at Achieving Viral Suppression During Late-Term Pregnancy, New Study Shows Img
Conference Coverage

Dolutegravir More Effective Than Efavirenz at Achieving Viral Suppression During Late-Term Pregnancy, New Study Shows

Unlike some previous studies that focused on early pregnancy, this study showed no associated congenital disabilities with either drug.

Promo Image
News

This Week in HIV Research: The Science of Risk

Traditional factors vs. HIV-specific factors in non-communicable complications; frailty and fracture risk among women; lipid measurements and coronary risks; new data on efavirenz and birth defects.

Eric Daar, M.D., and Claudia S. Crowell, M.D., M.P.H.
Children (Ages 0-17)

Neurological Conditions More Likely Among Children Exposed to Efavirenz in Utero

Efavirenz (Sustiva, Stocrin) use was associated with a 60% increased risk of neurological conditions in children, according to data presented at IDWeek 2018 in San Francisco.

Efavirenz Side Effects and Other Drug-Drug Interactions Are Common in Ugandan Cohort Img
Uganda

Efavirenz Side Effects and Other Drug-Drug Interactions Are Common in Ugandan Cohort

Drug-drug interactions and side effects, associated with currently-used first-line antiretroviral therapy, are under-reported and managed in Uganda.

Efavirenz Might Decrease Effectiveness of the Vaginal Contraceptive Ring Img
CROI (Conference on Retroviruses and Opportunistic Infections)

Efavirenz Might Decrease Effectiveness of the Vaginal Contraceptive Ring

Efavirenz (Sustiva, Stocrin) alters hormone exposure from the vaginal ring in HIV positive women, similar or greater to that previously reported with oral hormonal contraceptives.

Promo Image
Neurocognitive

This Week in HIV Research: This Is Your Brain on (HIV) Drugs

NeuroAIDS while on efavirenz vs. common NRTIs; HIV and the smoking cessation aid varenicline; PrEP adherence after positive partners start treatment; and Ugandans underreporting their antiretroviral use.

High Rates of Undocumented Efavirenz-Related Side Effects in Uganda Img

High Rates of Undocumented Efavirenz-Related Side Effects in Uganda

Although central nervous system side effects associated with efavirenz have led to newer drugs being recommended in in high income countries, WHO guidelines for low and middle income countries still recommend efavirenz for first-line therapy.

How a Gene Test Can Solve Side Effects Linked to Antiretroviral Drugs in Africa Img

How a Gene Test Can Solve Side Effects Linked to Antiretroviral Drugs in Africa

Researchers set out to find a way for HIV-positive people to continue using efavirenz (Sustiva, Stocrin) at lower doses in an effort to reduce severe side effects.